Abstract：Objective To investigate the distribution and drug sensitivity of pathogens and risk factors for ventilator-associated pneumonia (VAP) in children with congenial heart disease (CAD) after surgery. Methods According to the occurrence of VAP, 312 children with CAD who received mechanical ventilation after surgery for 48 hours or longer between January 2012 and December 2014 were classified into VAP (n=53) and non-VAP groups (n=259). Sputum samples were collected and cultured for pathogens in children with VAP. The drug sensitivity of pathogens was analyzed. The risk factors for postoperative VAP were identified by multiple logistic regression analysis. Results The sputum cultures were positive in 51 out of 53 children with VAP, and a total of 63 positive strains were cultured, including 49 strains of Gram-negative bacteria (78%), 9 strains of Gram-positive bacteria (14%) and 5 strains of funqi (8%). The drug sensitivity test showed that Gram-negative bacteria were resistant to amoxicillin, piperacillin, cefotaxime and ceftazidime, with a resistance rate of above 74%, and demonstrated a sensitivity to amikacin, polymyxin and meropenem (resistance rate of 19%-32%). Single factor analysis showed albumin levels, preoperative use of antibiotics, duration of mechanical ventilation, times of tracheal intubation, duration of anesthesia agent use, duration of acrdiopulmonary bypass, duration of aortic occlusion and use of histamin2-receptor blockade were significantly different between the VAP and non-VAP groups (PConclusions Gram-nagative bacteria are main pathogens for VAP in children with CAD after surgery. The antibiotics should be used based on the distribution of pathogens and drug sensitivity test results of pathogens. The effective measures for prevention of VAP should be taken according to the related risk factors for VAP to reduce the morbidity of VAP in children with CAD after surgery.
SUN Yue-Lin,FU Yue-Qiang,MA Hong-Tu et al. Pathogens and risk factors for ventilator-associated pneumonia in children with congenial heart disease after surgery[J]. CJCP, 2015, 17(11): 1204-1209.
Su F, El-Komy MH, Hammer GB, et al. Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease[J]. Biopharm Drug Dispos, 2015, 36(2): 104-114.
[2]
Willson DF. Outcomes and risk factors in pediatric ventilator-associated pneumonia: guilt by association[J]. Pediatr Crit Care Med, 2015, 16(3): 299-301.
[3]
Holloway AJ, Spaeder MC, Basu S, et al. Association of timing of tracheostomy on clinical outcomes in PICU patients[J]. Pediatr Crit Care Med, 2015, 16(3): e52-e58.
Matsuno AK, Carlotti AP. Role of soluble triggering receptor expressed on myeloid cells-1 for diagnosing ventilator-associated pneumonia after cardiac surgery: an observational study[J]. BMC Cardiovasc Disord, 2013, 13: 107.
[9]
Tang CW, Liu PY, Huang YF, et al. Ventilator-associated pneumonia after pediatric cardiac surgery in southern Taiwan[J]. J Microbiol Immunol Infect, 2009, 42(5): 413-419.
Seligman R, Seligman BG, Teixeira PJ. Comparing the accuracy of predictors of mortality in ventilator-associated pneumonia[J]. J Bras Pneumol, 2011, 37(4): 495-503.
[12]
Carron M, Rossi S, Carollo C, et al. Comparison of invasive and noninvasive positive pressure ventilation delivered by means of a helmet for weaning of patients from mechanical ventilation[J]. J Crit Care, 2014, 29(4): 580-585.
